# 68Ga-P3 PET/CT Imaging in Malignancy

> **NCT05887687** · NA · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 350 (estimated)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** [68Ga]P3

## Key facts

- **NCT ID:** NCT05887687
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-20
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05887687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05887687, "68Ga-P3 PET/CT Imaging in Malignancy". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05887687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*